Results 71 to 80 of about 16,082 (221)

First Experience With Extravascular Implantable Cardioverter‐Defibrillator Under Deep Sedation

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background The Extravascular Implantable Cardioverter‐Defibrillator (EV‐ICD) utilizes a substernal lead to provide defibrillation and anti‐tachycardia pacing (ATP) while avoiding transvenous complications. General anesthesia (GA) was applied for implantation procedures in the EV‐ICD pivotal trial and is currently recommended by the ...
Nibras Soubh, Bernhard C. Danner, Ulrich Krause, Matthias J. Müller, Markus Zabel, Gerd Hasenfuß, Constanze Schmidt, Helge Haarmann, Eva Rasenack, Leonard Bergau   +9 more
wiley   +1 more source

Clinical implications of troponin-T elevations following TAVR: Troponin Increase following TAVR

, 2021
BACKGROUND: Baseline and post-procedural elevations in serum troponin-T levels are associated with increased morbidity and mortality following transcatheter aortic valve replacement (TAVR).
Tanaka, Shuhei, Imamura, Teruhiko, Fukuda, Nobuyuki, Ueno, Hiroshi, Narang, Nikhil, Onoda, Hiroshi, Oshima, Akira, Kinugawa, Koichiro, Ushijima, Ryuichi, Sobajima, Mitsuo   +9 more
core   +1 more source

Standardized MRI‐Based Quantification of Epicardial Adipose Tissue Volume: Reproducibility and Agreement With Cardiac Computed Tomography

Journal of Magnetic Resonance Imaging, Volume 64, Issue 4, Page 1052-1063, October 2026.
ABSTRACT Background Epicardial adipose tissue volume (EATV) is increasingly recognized as a cardiometabolic risk marker associated with adverse outcomes. The most established approach for EATV quantification is cardiac computed tomography (CT). MRI offers a radiation‐free alternative allowing simultaneous assessment of myocardial function and tissue ...
Judith Gronwald, Svante S. Gersch, Zoé Böttiger, Clara Hagedorn, Torben Lange, Sören J. Backhaus, Sebastian Kelle, Constanze Schmidt, Karl Toischer, Andreas Schuster, Alexander Schulz   +10 more
wiley   +1 more source

The Management of Coronary Artery Disease in TAVR Patients

, 2023
About half of the transcatheter aortic valve replacement (TAVR) recipients exhibit some degree of coronary artery disease (CAD), and controversial results have been reported regarding the impact of the presence and severity of CAD on clinical outcomes ...
Aurélien Villecourt, Laurent Faroux, Damien Metz   +2 more
core   +1 more source

Comparative Outcomes of Transcatheter Versus Surgical Pulmonary Valve Replacement in Adults With Congenital Heart Disease

Catheterization and Cardiovascular Interventions, Volume 108, Issue 3, Page 792-800, September 1, 2026.
ABSTRACT Background Pulmonary valve replacement is frequently required in adults with congenital heart disease (CHD). Comparative real‐world outcomes between percutaneous transcatheter pulmonary valve implantation (TPVR) and surgical pulmonary valve replacement (SPVR) remain incompletely characterized. We evaluated outcomes and resource utilization for
Adam Bolad, Mohamed Elganainy, Fawaz Alenezi, Issam Motairek, Islam Bolad   +4 more
wiley   +1 more source

TAVR-in-TAVR in Surgical Valve for Recurrence of Failed Bioprosthesis

JACC: Case Reports
We present a case of a transcatheter aortic valve implantation in patient with a recurrent aortic bioprosthetic valve failure. Concerns about left main coronary artery occlusion led to a protective stent placement, ensuring successful Evolut R implantation.
Truong, Tony, Gallet, Romain, Teiger, Emmanuel, Boukantar, Madjid   +3 more
openaire   +2 more sources

Consecutive Emergency Carotid Artery Stenting and Transcatheter Aortic Valve Replacement in a Patient With Cardiogenic Shock: A Case Report

Catheterization and Cardiovascular Interventions, Volume 108, Issue 3, Page 1047-1051, September 1, 2026.
ABSTRACT Severe aortic stenosis (AS) carries a poor prognosis when symptomatic, particularly in cardiogenic shock (CS). Emergency transcatheter aortic valve replacement (TAVR) is rarely performed but may represent a rescue therapy. Coexistent carotid artery stenosis (CAS) further increases procedural risk.
Max Groche, Claudio Silwanis, Clemens Steinwender, Thomas Lambert   +3 more
wiley   +1 more source

Biological findings prior to TAVR.

, 2021
Biological findings prior to TAVR.
Patrick Ohlmann (5746850), Kensuke Matsushita (10314953), Sébastien Hess (11772886), Antonin Trimaille (11255899), Joé Heger (11772889), Marion Kibler (11255893), Benjamin Marchandot (10314956), Lelia Grunebaum (4673371), Laurence Jesel (10314962), Adrien Carmona (11255896), Olivier Morel (502242), Antje Reydel (11255890), Laurent Sattler (10033774)   +12 more
core   +1 more source

TAVR-in-TAVR with a balloon-expandable valve for paravalvular leak

Frontiers in Cardiovascular Medicine
IntroductionParavalvular leak (PVL) is a severe complication of transcatheter aortic valve replacement (TAVR) that can lead to poor outcomes. TAVR-in-TAVR is a promising treatment for PVL; however, reports on its safety or efficacy are limited. In this study, we aimed to investigate the clinical outcomes of TAVR-in-TAVR using balloon-expandable ...
Takashi Nagasaka, Takashi Nagasaka, Vivek Patel, Ofir Koren, Ofir Koren, Alon Shechter, Alon Shechter, Tarun Chakravarty, Wen Cheng, Hideki Ishii, Hasan Jilaihawi, Mamoo Nakamura, Raj R. Makkar   +12 more
openaire   +3 more sources

miR‐138‐5p Inhibits Aortic Valve Interstitial by Targeting SLC39A14 and Activating Nrf2 Signaling

Journal of Biochemical and Molecular Toxicology, Volume 40, Issue 9, September 2026.
Nrf2 Pathway Inhibition Attenuates miR‐138‐5p's Anti‐Calcification Effects in OM‐Induced hAVICs. A. ALP staining for ALP activity assessment in NC‐mimic, miR‐mimic, and miR‐mimic + ML385 groups. B. Alizarin Red staining for osteogenesis and calcium nIn osteogenic medium‐induced human aortic valve interstitial cells (hAVICs), miR‐138‐5p targets SLC39A14
Fei Yan, Ying Zhao, Yuanyuan Wu, Dubiao Xian, Lei Shi, Yunheng Liang, Ning Wang, Ruiling He, Hongwang Cui, Zhihao Xie   +9 more
wiley   +1 more source